Literature DB >> 15093814

Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides.

Gjermund Henriksen1, B W Schoultz, T E Michaelsen, Ø S Bruland, R H Larsen.   

Abstract

The alpha-particle emitting radionuclides (223)Ra (t(1/2) = 11.4 d), (224)Ra (t(1/2) = 3.6 d), and (225)Ac(t(1/2) = 10.0 d) may have a broad application in targeted radiotherapy provided that they could be linked to vehicles with tumor affinity. The potential usefulness of liposomes as carriers was studied in the present work. Radium and actinium radionuclides could be loaded in good yields into sterically stabilized liposomes. Subsequent coating of the liposomes with a folate-F(ab')(2) construct yielded a product with affinity towards tumor cells expressing folate receptors. Radionuclide loaded liposomes showed excellent stability in serum in vitro.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15093814     DOI: 10.1016/j.nucmedbio.2003.11.004

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  22 in total

1.  Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches.

Authors:  Nikki A Thiele; Justin J Wilson
Journal:  Cancer Biother Radiopharm       Date:  2018-06-11       Impact factor: 3.099

2.  Branched amphiphilic peptide capsules: cellular uptake and retention of encapsulated solutes.

Authors:  Pinakin Sukthankar; L Adriana Avila; Susan K Whitaker; Takeo Iwamoto; Alfred Morgenstern; Christos Apostolidis; Ke Liu; Robert P Hanzlik; Ekaterina Dadachova; John M Tomich
Journal:  Biochim Biophys Acta       Date:  2014-02-22

Review 3.  A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules.

Authors:  Sheila M Barros; Susan K Whitaker; Pinakin Sukthankar; L Adriana Avila; Sushanth Gudlur; Matt Warner; Eduardo I C Beltrão; John M Tomich
Journal:  Arch Biochem Biophys       Date:  2016-02-27       Impact factor: 4.013

Review 4.  Applications of 211At and 223Ra in targeted alpha-particle radiotherapy.

Authors:  Ganesan Vaidyanathan; Michael R Zalutsky
Journal:  Curr Radiopharm       Date:  2011-10

Review 5.  Cancer radioimmunotherapy with alpha-emitting nuclides.

Authors:  Olivier Couturier; Stéphane Supiot; Marie Degraef-Mougin; Alain Faivre-Chauvet; Thomas Carlier; Jean-François Chatal; François Davodeau; Michel Cherel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-05       Impact factor: 9.236

Review 6.  Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications.

Authors:  Matthias Miederer; David A Scheinberg; Michael R McDevitt
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

7.  Functionalized NaA nanozeolites labeled with 224,225Ra for targeted alpha therapy.

Authors:  Agata Piotrowska; Edyta Leszczuk; Frank Bruchertseifer; Alfred Morgenstern; Aleksander Bilewicz
Journal:  J Nanopart Res       Date:  2013-10-31       Impact factor: 2.253

Review 8.  Targeted and Nontargeted α-Particle Therapies.

Authors:  Michael R McDevitt; George Sgouros; Stavroula Sofou
Journal:  Annu Rev Biomed Eng       Date:  2018-01-18       Impact factor: 9.590

9.  Molecular imaging and therapy of cancer with radiolabeled nanoparticles.

Authors:  Hao Hong; Yin Zhang; Jiangtao Sun; Weibo Cai
Journal:  Nano Today       Date:  2009-10-01       Impact factor: 20.722

10.  Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy-Part II. Toxicity, Pharmacokinetics and Biodistribution.

Authors:  Anna Lankoff; Malwina Czerwińska; Rafał Walczak; Urszula Karczmarczyk; Kamil Tomczyk; Kamil Brzóska; Giulio Fracasso; Piotr Garnuszek; Renata Mikołajczak; Marcin Kruszewski
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.